The options were granted in accordance with Nasdaq Listing Rule 5635(4).
The options have an exercise price of
About
Contact:
Email: ir@akebia.com
(C) 2020 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | -2.92% | -4.32% | +7.26% |
Apr. 23 | Averoa Seeks EU Approval for Chronic Kidney Disease Drug | MT |
Apr. 16 | Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited Enters into Second Amendment to the Supply Agreement | CI |
The options were granted in accordance with Nasdaq Listing Rule 5635(4).
The options have an exercise price of
About
Contact:
Email: ir@akebia.com
(C) 2020 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+7.26% | 278M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.23% | 22.02B | |
-17.84% | 20.9B | |
-9.14% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |